Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000359 · ClinicalTrials.gov registry record · Phase 2
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
A Phase 2 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00000359 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 150 participants.
The verdict
NCT00000359, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.
Interventions
- BEHAVIORAL Canalith repositioning maneuver (Epley maneuver)
- BEHAVIORAL Semont maneuver
- BEHAVIORAL Brandt-Daroff exercises
- BEHAVIORAL Vestibular habituation exercises
- BEHAVIORAL ShamManeuver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1998-10 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000359
The ClinicalTrials.gov registry entry for NCT00000359 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Canalith repositioning maneuver (Epley maneuver) is the first listed.
NCT00000359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000359 about?
NCT00000359 is a clinical study titled "Treatments for Benign Paroxysmal Positional Vertigo (BPPV)". The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, t...
What is the current status of trial NCT00000359?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 1998-10. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00000359?
The interventions under investigation include: Canalith repositioning maneuver (Epley maneuver) (BEHAVIORAL), Semont maneuver (BEHAVIORAL), Brandt-Daroff exercises (BEHAVIORAL), Vestibular habituation exercises (BEHAVIORAL), ShamManeuver (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000359?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.